Fatty liver develops when triglycerides (a type of fat) build up inside liver cells faster than the liver can process or export them. The most common cause is metabolic dysfunction, specifically insulin resistance and its related conditions like obesity and type 2 diabetes. An estimated 55 to 70% of people with type 2 diabetes have fatty liver. But alcohol, genetics, certain medications, gut health, and even sleep disorders can also drive fat accumulation in the liver, sometimes working together.
Metabolic Dysfunction: The Leading Cause
The vast majority of fatty liver cases are now classified under a condition called metabolic dysfunction-associated steatotic liver disease, or MASLD (previously known as NAFLD). To qualify for this diagnosis, a person has fat buildup in the liver plus at least one of five metabolic risk factors: a BMI of 25 or higher, elevated fasting blood sugar or type 2 diabetes, high blood pressure, high triglycerides, or low HDL cholesterol. Most people with fatty liver check more than one of those boxes.
The core problem is insulin resistance. When your cells stop responding normally to insulin, blood sugar stays elevated. The liver responds by ramping up its own fat production. Persistently high glucose inside liver cells activates a chain of events: sugar molecules get converted into building blocks for fat, and gene switches that normally keep fat production in check get turned on at full blast. One of these switches boosts fat-making genes while simultaneously making insulin resistance worse, creating a self-reinforcing cycle. At the same time, high sugar levels inside liver cells generate byproducts that cause proteins to misfold, triggering a stress response that further increases fat production.
On top of this internal fat manufacturing, insulin-resistant fat tissue releases more free fatty acids into the bloodstream, and the liver absorbs them. So fat arrives at the liver from two directions at once: the liver makes more of it internally, and more of it flows in from the rest of the body.
Alcohol and How It Overlaps With Metabolic Causes
Alcohol is processed in the liver through a pathway that shifts the liver’s internal chemistry away from burning fat. When your liver breaks down ethanol, it produces a chemical byproduct that tips the balance of key molecules (specifically the ratio of NADH to NAD+) in a way that directly inhibits fat burning. Alcohol also turns down the activity of a master regulator of fat oxidation genes, further slowing the liver’s ability to clear fat from its cells.
The updated naming system recognizes that many people have both metabolic risk factors and moderate-to-heavy alcohol use. A newer category called MetALD covers people who meet the criteria for metabolic fatty liver but also drink more than about 140 grams of alcohol per week for women or 210 grams per week for men. That translates to roughly 10 standard drinks per week for women and 15 for men. Below those thresholds, the diagnosis stays as MASLD; above them, alcohol becomes a significant contributing factor.
Genetic Risk: The PNPLA3 Variant
Some people develop fatty liver even without obvious metabolic problems, and genetics help explain why. The most well-studied genetic factor is a variant of the PNPLA3 gene, known as I148M. This gene normally produces an enzyme involved in breaking down fats inside liver cells and fat tissue. The variant version of the enzyme has reduced activity, meaning fat accumulates instead of being broken down and cleared. People who carry two copies of this variant (one from each parent) have a substantially higher risk of developing fatty liver, and if they do develop it, they’re more likely to progress to inflammation and scarring. This variant is especially common in people of Hispanic/Latino descent, which partly explains the higher rates of fatty liver in that population.
How Gut Bacteria Contribute
Your gut and liver are directly connected through the portal vein, which carries blood from the intestines straight to the liver. When the gut lining becomes “leaky,” bacterial toxins, particularly one called endotoxin, slip through into this blood supply and reach the liver. There, immune cells in the liver recognize these toxins and launch an inflammatory response that promotes both fat storage and liver damage.
The connection runs deeper than just leakiness. People with fatty liver tend to have altered gut bacteria that produce more ethanol as a natural fermentation byproduct. Studies have found that patients with the more severe, inflammatory form of fatty liver (called MASH) have higher blood alcohol levels even without drinking, with concentrations even higher in the vein leading directly to the liver. When this microbial alcohol production exceeds the liver’s processing capacity, it drives triglyceride buildup and cell death in much the same way that drinking alcohol does.
Gut bacteria in people with fatty liver also convert more primary bile acids into secondary bile acids that are directly toxic to liver cells. And a microbial metabolite called TMAO, produced when gut bacteria process certain nutrients found in red meat and eggs, circulates at higher levels in people with fatty liver and promotes fat accumulation in liver cells.
Sleep Apnea and Low Oxygen
Obstructive sleep apnea creates repeated drops in blood oxygen throughout the night, and this intermittent low oxygen directly affects the liver. The oxygen deprivation triggers the liver to take up more fatty acids from the bloodstream while simultaneously slowing down fat burning in the cell’s energy-producing structures. The net effect is more fat coming in and less going out.
Low oxygen also activates proteins called hypoxia-inducible factors. One of these, HIF-2, increases the liver’s capacity to pull fats out of the bloodstream by boosting the production of a specific fat-transporting receptor on liver cells. Chronic activation of HIF-2 in animal studies produces severe fatty liver. Beyond the liver itself, the intermittent oxygen drops from sleep apnea disrupt the gut microbiome and weaken the intestinal barrier, compounding liver damage through the gut-liver pathway described above. This is why treating sleep apnea can improve liver fat even without changes in diet or weight.
Medications That Cause Fatty Liver
Certain medications can cause fat to accumulate in the liver as a side effect. Methotrexate, used long-term for autoimmune conditions like rheumatoid arthritis and psoriasis, is one of the most well-documented examples. With chronic use, it can cause fatty liver, fibrosis, and eventually cirrhosis. Corticosteroids promote fat deposition in the liver by increasing insulin resistance and redirecting fat storage. Tamoxifen, used in breast cancer treatment, and certain older anti-seizure medications can also contribute. In most medication-related cases, the fatty liver improves or resolves after the drug is stopped or switched, though this depends on how long the medication was used and how much damage accumulated.
Fructose and Dietary Patterns
High fructose intake deserves special mention because of how the liver handles it differently from other sugars. Fructose is processed almost exclusively in the liver, where it produces a molecule that dramatically increases the activity of the liver’s primary sugar-processing enzyme, boosting the rate of glucose metabolism by roughly 3.4 to 4.4 times the normal rate during the absorptive period after eating. This floods the liver with raw materials for fat production. Fructose also activates the same gene switches involved in metabolic fatty liver, amplifying fat synthesis. This is why sugary drinks and foods with high-fructose corn syrup are consistently linked to fatty liver, even in people who aren’t overweight.
Diets high in refined carbohydrates and saturated fat promote the same pathways, just less dramatically than pure fructose. A pattern of excess caloric intake over time, particularly from carbohydrate-dense and processed foods, creates the sustained high blood sugar and insulin levels that keep the liver locked in fat-production mode.
Why Multiple Causes Often Stack
Fatty liver rarely results from a single isolated cause. More often, several factors layer on top of each other. Someone with the PNPLA3 gene variant who gains weight and develops mild insulin resistance will accumulate liver fat faster than someone without the variant. Add moderate alcohol use or untreated sleep apnea, and the progression accelerates further. The gut microbiome shifts that come with a high-sugar, high-fat diet feed back into liver inflammation, which worsens insulin resistance, which drives more fat into the liver. Understanding this is useful because it also means that addressing even one contributing factor, whether it’s weight, alcohol, sleep, or diet, can meaningfully reduce liver fat even if other risk factors remain.